The exploration for the palliative efficacy of Hochu-ekkitou in genitourinary cancer patient

The exploration for the palliative efficacy of Hochu-ekkitou in genitourinary cancer patient - HOPE Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023032

Enrollment

Registered

2016-07-20

Start date

2016-07-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic genitourinary cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Metastatic genitourinary cancer patients who were received at least one anticancer agent 2)Patients planed the next new anticancer agents 3)Over 20-year old patients 4)ECOG PS 0-1 5)Patients who accept the enrollment in the study 6) Patients who have proper bone marrow, renal, and liver function

Exclusion criteria

Exclusion criteria: Patients who do not accept the enrollment in the study

Design outcomes

Primary

Measure	Time frame
QOL Measuring IL-6, IL-1 beta, TNF alpha as the cachexia marker	—

Countries

Japan

Contacts

Public ContactSatoshi Anai

Nara Medical University Dept. of Urology

sanai@naramed-u.ac.jp0744-22-3051

Outcome results